NCT06733519View on ClinicalTrials.gov

TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 1, 2026

Primary Completion Date

March 1, 2027

Study Completion Date

June 1, 2027

Conditions

PruritusPrimary Biliary Cholangitis

Interventions

DRUG

Nalmefene

Th-104 Nalmefene Mucoadhesive Buccal strip

DRUG

Placebo

Matching placebo to TH-104

All Listed Sponsors

lead

Tharimmune Inc

INDUSTRY